RET, ROS1 and ALK fusions in lung cancer

Keywords

ROS1Anaplastic lymphoma kinaseCancer researchAdenocarcinomaOncogeneLung cancerReceptor tyrosine kinaseTyrosine kinaseFusion geneCancerKinaseViral OncogeneTargeted therapyCrizotinibBiologyMedicineOncologyInternal medicineReceptorGeneGeneticsCell cycle

Affiliated Institutions

Related Publications

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network

Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA ...

2014 Nature 5605 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi , Delvys Rodríguez‐Abreu , Shirish M. Gadgeel +26 more

In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...

2018 New England Journal of Medicine 6245 citations

Diagnosing and Managing Advanced Chronic Myeloid Leukemia

Michael W. Deininger

Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural h...

2015 American Society of Clinical Oncology... 28 citations

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

Elias Jabbour , Hagop M. Kantarjian

Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...

2014 American Journal of Hematology 210 citations

The biology and management of non-small cell lung cancer

Roy S. Herbst , Daniel Morgensztern , Chris Boshoff

2018 Nature 4607 citations

Publication Info

Year: 2012
Type: article
Volume: 18
Issue: 3
Pages: 378-381
Citations: 1309
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

RET, ROS1 and ALK fusions in lung cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1309

OpenAlex

Cite This

APA Style

                            
                                
                                    Kengo Takeuchi, 
                                
                                    Manabu Soda, 
                                
                                    Yuki Togashi
                                
                                et al.
                            
                            (2012). 
                            RET, ROS1 and ALK fusions in lung cancer. 
                            Nature Medicine
                            , 18
                            (3)
                            , 378-381.
                            https://doi.org/10.1038/nm.2658
                        

Identifiers

DOI: 10.1038/nm.2658